Sheila Kumar, M.D., M.S.

Professional Experience

• M.S. in Epidemiology and Clinical Research, Department of Health Research and Policy, Stanford University School of Medicine, 2013-2014
• Fellow, Gastroenterology and Hepatology, Division of Gastroenterology, Department of Medicine, Stanford University School of Medicine, 2011-2014
• Research Fellow (Pancreas), Pancreas Cancer Genetics and Prevention Program, Division of Digestive and Liver Diseases, Department of Medicine, New York-Presbyterian/Columbia University Medical Center, 2010-2011
• Intern and Resident, Department of Medicine, New York-Presbyterian/Columbia University Medical Center, 2007-2010
• M.D., Yale University School of Medicine, 2003-2007
• B.A. with Honors, Johns Hopkins University, 1999-2003

Select Publications

Absence of pancreatic intraepithelial neoplasia predicts poor survival after resection of pancreatic cancer.

Hassid BG, Lucas AL, Salomao M, Weng C, Liu F, Khanna LG, Kumar S, Hwang C, Chabot JA, Frucht H.

Pancreas (2014 Oct) 43:1073-7. Abstract/Full Text

BRCA1 and BRCA2 germline mutations are frequently demonstrated in both high-risk pancreatic cancer screening and pancreatic cancer cohorts.

Lucas AL, Frado LE, Hwang C, Kumar S, Khanna LG, Levinson EJ, Chabot JA, Chung WK, Frucht H.

Cancer (2014 Jul 1) 120:1960-7. Abstract/Full Text